Sourcing Guide: Key Factors in Sugar Glucagon Peptide Product Composition
Abstract: This sourcing guide analyzes key factors in sugar glucagon peptide product composition, leveraging market data showing a 12.4% CAGR in peptide therapeutics. We compare leading brands (e.g., Novo Nordisk, Eli Lilly) on purity (>98% vs. 95%), stability, and cost. Technical advantages include targeted glucose regulation; disadvantages involve short half-lives. Product parameters (e.g., molecular weight, excipient profiles) and certifications (GMP, ISO 9001) are critical for quality. Applications span diabetes management and metabolic disorders. Current industry trends emphasize lyophilized formulations for logistics efficiency. Selection tips prioritize verified factory audits and batch-specific COAs to ensure compliance and efficacy.